Results 41 to 50 of about 1,768 (165)

Therapy for hilar cholangiocarcinoma

Сибирский онкологический журнал, 2019
Purpose: to present different modalities of biliary decompression and specific antitumor treatment of hilar cholangiocarcinoma (Klatkin tumor). material and methods.
D. Yu. Frantsev, O. N. Sergeeva, B. I. Dolgushin   +2 more
doaj   +1 more source

A Case of Bilio‐Bronchial Fistula Presenting With Bilioptysis Following Hepatocellular Carcinoma Treatment

Respirology Case Reports, Volume 14, Issue 1, January 2026.
We present a detailed case of a bilio‐bronchial fistula that developed in a complex, multitreated HCC patient, illustrating a plausible causal chain from liver resection and ablation to fistula formation. This report underscores bilio‐bronchial fistula as a potential late complication of hepatic ablative therapy, highlights the critical importance of ...
Chin‐Tong Kwok, Kar‐Vin Chan, Sai‐On Ling, Patrick Tam, Cee‐Kin Tseng, Yiu‐Fai Cheung, Chie‐Wai Yim, Thomas Mok, Chi‐Hung Lau, Hoi‐Yee Kwan   +9 more
wiley   +1 more source

Therapeutical Concepts and Results for Klatskin Tumors [PDF]

Deutsches Ärzteblatt international, 2008
Most hilar cholangiocarcinomas (Klatskin tumors) are diagnosed at an advanced stage. This article aims to review the literature of resection and palliative treatment in patients with hilar cholangiocarcinoma.All studies with evidence levels I and II and relevant trials with evidence level III from 1996 to 04/2007 were included.The definition of ...
Helmut, Witzigmann, Marcus, Wiedmann, Christian, Wittekind, Joachim, Mössner, Johann, Hauss   +4 more
openaire   +2 more sources

Sister Mary Joseph's Nodule Revealing Klatskin's Cholangiocarcinoma at the Yalgado Ouedraogo University Hospital: Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Umbilical cutaneous metastases of abdomino‐pelvic tumors are rare. They are known as Sister Mary Joseph nodules. The presence of this nodule indicates an advanced cancerous lesion and is associated with a poor prognosis. Because of its rarity, the Sister Mary Joseph nodule can go unnoticed.
Lawagoulé Joseph Emile Ky, Eric Hervé Mourfou, Abdoul Fatao Maïga, Daouda Sangaré, Damien Marcel Traoré, Saïdou Santi, Madina Koanda, Alimata Sanfo, Delphine Napon/Zongo, Aboubacar Coulibaly, Kounpiélimé Sosthène Somda, Arsène Roger Sombié   +11 more
wiley   +1 more source

Prognosis and Chemotherapeutic Efficacy in Extrahepatic Cholangiocarcinoma With Lung Metastases

Cancer Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Objective Studies on lung metastases from extrahepatic cholangiocarcinoma (ECC) are rare. This study aims to fill this gap by analyzing the influencing factors, prognosis, and chemotherapeutic efficacy of ECC lung metastases, and to provide insights for optimizing medical care for patients with ECC lung metastases.
Chao Zhang, Shun Tu, Yanting Liao, Yaqiang Shu, Muyu Fu, Jiayue Li, Xiaohua Lei   +6 more
wiley   +1 more source

Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)

Frontiers in Oncology, 2022
BackgroundLiver transplantation (LT) is considered a therapeutic option for unresectable perihilar cholangiocarcinoma (PHC) within defined criteria.
Moritz Schmelzle, Moritz Schmelzle, Christian Benzing, Lutz Fischer, Uta Herden, Martina Sterneck, Utz Settmacher, Astrid Bauschke, Ulf Neumann, Uwe Pelzer, Tobias Müller, Christian Strassburg, Hauke Lang, Thomas Becker, Alfred Königsrainer, Silvio Nadalin, Markus Quante, Andreas Paul, Helmut Friess, Jürgen Klempnauer, Nicolas Richter, Florian Vondran, Andreas Pascher, Thomas Rösch, Wenzel Schöning, Felix Krenzien, Robert Öllinger, Daniel Seehofer, Peter Neuhaus, Johann Pratschke   +29 more
doaj   +1 more source

Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 5, May 2025.
ABSTRACT Background The absence of validated methods to identify cholangiocarcinoma in real‐world data has prevented the conduct of pharmacoepidemiologic studies to evaluate determinants of this malignancy and examine the effectiveness of cholangiocarcinoma treatments.
Nicole D. Ferrante, Rebecca A. Hubbard, Kelley Weinfurtner, Anya I. Mezina, Craig W. Newcomb, Emma E. Furth, Debika Bhattacharya, Basile Njei, Tamar H. Taddei, Amit Singal, Maarouf A. Hoteit, Lesley S. Park, David Kaplan, Vincent Lo Re III   +13 more
wiley   +1 more source

Dynamics of the serum bilirubin level during bile ducts drainage in patients with hilar tumor stenosis and jaundice

Journal of Education, Health and Sport, 2021
Palliative bile duct decompression with various modifications are currently performed in 75-80% of patients with hilar stenosis caused by the tumor. The main goal of palliative care is to reduce the manifestations of jaundice, intoxication, pain syndrome,
R. Palytsya, L. Markulan, Ie. Tsema, D. Dubenko, A. Batiuk, Ya. Susak   +5 more
doaj   +1 more source

Chemoradiation of locally advanced biliary cancer: A PRISMA‐compliant systematic review

Cancer Medicine, Volume 13, Issue 23, December 2024.
This is a systematic review of the current evidence on “modern” chemoradiation for primary or recurrent unresectable biliary tract cancers. We have critically compared chemoradiation outcomes with those of other treatment options, seeking to determine whether specific chemoradiation modalities provide distinct advantages in terms of treatment efficacy ...
Silvia Bisello, Claudio Malizia, Filippo Mammini, Erika Galietta, Federica Medici, Gian Carlo Mattiucci, Francesco Cellini, Andrea Palloni, Luca Tagliaferri, Gabriella Macchia, Francesco Deodato, Savino Cilla, Giovanni Brandi, Alessandra Arcelli, Alessio G. Morganti   +14 more
wiley   +1 more source

Challenges of the Klatskin tumor diagnosis in a patient suffering from cirrhosis of the liver

Медицинский совет, 2013
The clinical example demonstrates several stages of diagnostic search in patients admitted to hospital with severe manifestations of cholestatic syndrome.
I. V. Mayev, T. V. Penkina, D. N. Andreyev, D. T. Dicheva, Yu. S. Subbotina   +4 more
doaj   +1 more source